In: Plos one, 2013, vol. 8, no. 9, p. e74045
More effective treatment of metastasizing osteosarcoma with a current mean 5-year survival rate of less than 20% requires more detailed knowledge on mechanisms and key regulatory molecules of the complex metastatic process. CXCR4, the receptor of the chemokine CXCL12, has been reported to promote tumor progression and metastasis in osteosarcoma. CXCR7 is a recently deorphanized...
|
In: Pharmaceutical Research, 2004, vol. 21, no. 1, p. 33-42
|
In: Biomedical Microdevices, 2011, vol. 13, no. 2, p. 291-301
|
In: Investigational New Drugs, 2007, vol. 25, no. 4, p. 305-312
|
In: Investigational New Drugs, 2008, vol. 26, no. 4, p. 289-297
|